WITHDRAWN: Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

WITHDRAWN: Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis

Published:2018-05 Issue: Volume: Page:
ISSN:2542-5684
Container-title:Liver Research
language:en
Short-container-title:Liver Research

Author:

Kersten Cassandra A.^ORCID,Sloey Elise N.,Zhou Eric,Peng Ying^ORCID,Torbenson Michael S.,Guo Yi

Funder

Mayo Clinic Graduate Research Employment Program

Mayo Clinic Summer Undergraduate Research Fellow program

Mayo Clinic New Investigator Startup Fund

Mayo Clinic Center for Biomedical Discovery Platform Grant

Fibrolamellar Cancer Foundation Research Grant

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference62 articles.

1. Fibrolamellar hepatocellular carcinoma: current clinical perspectives;Lafaro;J Hepatocell Carcinoma,2015

2. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma;Honeyman;Science,2014

3. Genomic analysis of fibrolamellar hepatocellular carcinoma;Xu;Hum Mol Genet,2015

4. Unique genomic profile of fibrolamellar hepatocellular carcinoma;Cornella;Gastroenterology,2015

5. Fibrolamellar hepatocellular carcinoma in mexican patients;Arista-Nasr;Pathol Oncol Res,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP